Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
iCELL-IA
- Development stage
- Unknown
- Lead developer
- iCell Gene Therapeutics
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intrauterine
01
Overview
iCELL-IA is a cell therapy product developed by iCELL Biotechnology that utilizes human amniotic epithelial stem cells (hAESCs) for the treatment of intrauterine adhesions (IUA), also known as Asherman's syndrome. hAESCs are derived from the amniotic membrane and are characterized by their low immunogenicity, immunomodulatory properties, and high proliferative potential. The therapy aims to promote endometrial regeneration and restore uterine function by reducing fibrosis through the regulation of markers such as Transforming growth factor beta (TGF-β), enhancing angiogenesis, and providing paracrine support to the endometrial microenvironment. iCELL-IA is currently in Phase 1/2 clinical development, with studies focusing on its safety and efficacy in patients with refractory severe intrauterine adhesions.
- Other names
- Human Amniotic Epithelial Stem CellshAESCsHuman Amniotic Epithelial CellshAECs
Beyond the preview
Go deeper on iCELL-IA.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on iCELL-IA.